Baseline à End-program Baseline à Follow-up |
Mean Effect Mean Effect |
change t p size change t p size |
Disability (RMDS) -4.26 -4.9 .000*** 1.25 -5.53 -5.5 .000*** 1.33 |
|
Perceived stress (PSS) -0.31 -3.4 .003** 0.54 - 0.34 -2.7 .016* 0.44 |
|
Health Scales (SF-36) |
Physical health 0.47 4.5 .000*** 1.00 0.66 7.5 .000*** 1.29 |
Physical functioning 0.52 4.5 .000*** 1.00 0.27 4.8 .000*** 0.84 |
Role—physical 0.56 3.4 .003** 0.79 0.83 5.8 .000*** 1.11 |
Bodily pain - 0.73 -4.6 .000*** 1.00 -1.05 -6.1 .000*** 1.33 |
General health 0.08 1.0 .341 0.29 0.20 2.4 .026* 0.46 |
|
Mental health 0.28 3.3 .003** 0.59 0.39 4.0 .001** 0.73 |
Vitality 0.35 2.4 .025* 0.46 0.62 -4.0 .001** 0.91 |
Social functioning -0.02 -0.3 .747 0.20 0.00 0.0 1.000 0.13 |
Role—emotional 0.39 2.6 .017* 0.46 0.44 3.0 .007** 0.41 |
Mental well-being 0.39 3.1 .005** 0.65 0.52 -3.3 .004** 0.75 |
Change in health 0.55 2.7 .015* 0.58 0.68 2.5 .027* 0.89 |
|
Mood disturbance (POMS) - 0.34 -3.2 .004** 0.61 - 0.46 -4.4 .000*** 0.73 |
Tension/anxiety - 0.28 -2.0 .064~ 0.35 - 0.40 -2.9 .010** 0.50 |
Depression/dejection - 0.39 -3.1 .006** 0.65 - 0.38 -3.3 .004** 0.58 |
Anger/hostility - 0.42 -3.7 .001** 0.75 - 0.39 -3.1 .006** 0.58 |
Fatigue - 0.42 -2.6 .016* 0.46 - 0.72 -3.5 .003** 0.70 |
Confusion/bewilder- - 0.32 -2.2 .042* 0.60 -2.78 -3.5 .002** 0.46 |
Vigor/activity 0.20 0.8 .444 0.20 0.54 2.6 .019* 0.57 |
|
Bothersomeness - 2.40 -4.7 .000*** 1.29 -3.03 -6.0 .000*** 1.53 |
Use of medication -0.14 -1.4 .186 0.28 0.00 0.0 1.000 0.12 |